Vasopressin in pediatric vasodilatory shock: a multicentred randomized controlled trial

@inproceedings{Choong2009VasopressinIP,
  title={Vasopressin in pediatric vasodilatory shock: a multicentred randomized controlled trial},
  author={Karen L M Choong and Desmond J Bohn and Douglas D. Fraser},
  booktitle={American journal of respiratory and critical care medicine},
  year={2009}
}
RATIONALE Vasopressin has been proposed as a potent vasoactive agent in the treatment of vasodilatory shock in adults and children. The objective of this trial was to evaluate the efficacy and safety of vasopressin as an adjunctive agent in pediatric vasodilatory shock. METHODS In this multicenter, double-blind trial, children with vasodilatory shock were randomized to receive low-dose vasopressin (0.0005-0.002 U/kg/min) or placebo in addition to open-label vasoactive agents. Vasoactive… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Update on pediatric sepsis: a review

Journal of intensive care • 2017
View 12 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…